Back to Search
Start Over
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
- Source :
- The Fly. April 28, 2020
- Publication Year :
- 2020
-
Abstract
- Guggenheim analyst Yatin Suneja raised the firm's price target on Axsome Therapeutics to $200 from $158 and keeps a Buy rating on the shares. The company's positive Alzheimer's agitation data [...]
- Subjects :
- Brexpiprazole
Alzheimer's disease
Business
News, opinion and commentary
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.622181452